A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi.
about
HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsRising to the challenge of multiple Cryptococcus species and the diseases they cause.Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents.Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.Dosing of antifungal agents in obese people.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.Multiple Applications of a Transient CRISPR-Cas9 Coupled with Electroporation (TRACE) System in the Cryptococcus neoformans Species Complex.The war on cryptococcosis: A Review of the antifungal arsenal.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal MeningitisPresent and Future Therapy of InfectionsAn audit of the screen-and-treat intervention to reduce cryptococcal meningitis in HIV-positive patients with low CD4 count
P2860
Q28078958-66D67B65-E240-4C34-BD07-E8A2512B65D3Q35706177-46D2961C-9EC1-4FDE-AF2E-F6DA72EFA1CBQ35744569-01048F7D-51EC-492B-8316-4541886D5973Q36167708-F1946DCA-621F-4D57-982B-F5ED2F72AFB2Q36290696-D486071B-B02B-4997-9627-D6C98864D988Q38660761-A1B49A01-274E-49D0-BF72-EAF2ABA64434Q39379643-AFC68909-63E6-4802-A1F5-258B70943097Q52378738-88C68276-6CB7-476F-AACE-7FA2352DF375Q54260674-59270C95-7F8D-4823-8FF1-19261E7C886BQ55229762-F0498CF3-4D56-4FC6-8EF4-7D9DA7D6B397Q56910086-33977006-67B0-4326-8005-506DC2898E51Q57177336-50D545AF-423E-480A-880D-1577B0A254C7Q58794920-58D28F1D-3DA1-4930-AFAD-C44B3235AA54
P2860
A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@ast
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@en
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@nl
type
label
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@ast
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@en
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@nl
prefLabel
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@ast
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@en
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@nl
P2093
P2860
P50
P1433
P1476
A prospective study of mortali ...... uconazole in Blantyre, Malawi.
@en
P2093
Camilla Rothe
Chikondi Jassi
Patrick Goodson
Roshina Gnanadurai
Theresa J Allain
P2860
P304
P356
10.1371/JOURNAL.PONE.0110285
P407
P577
2014-11-06T00:00:00Z